Projects

Ing. Jana Tomášková, PhD.

National

Current
  • The role of cellular lipids in lymphocytic choriomeningitis virus life cycle
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2026
Finished
  • Reprogramming of host cell metabolism induced by lymphocytic choriomeningitis virus infection
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2022
  • Molecular pathways influenced by CA IX in hypoxic cancer cell lines
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2018
  • Impact of LCMV infection on the activity of HIF-regulated signal transduction pathways
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2018
  • Centre for Innovative Research of Antitumor and Antiviral Strategies
    Program: EU Structural Funds Research & Development
    Duration: 1. 5. 2011 – 31. 8. 2015
  • Identification of the cellular proteins affected by persistent infection with lymphocytic choriomeningitis virus
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2014
  • Identification of the molecular pathways driven by hypoxia-induced carbonic anhydrase IX in tumor cells
    Program: SRDA
    Duration: 1. 5. 2011 – 31. 10. 2014
  • Industrial Research in Clinical Diagnostics of Infectious Pathogens
    Program: EU Structural Funds Research & Development
    Duration: 1. 6. 2010 – 31. 5. 2013
  • Significance of the carbonic anhydrase IX as a non-invasive prognostic indicator and a molecular target in renal cell carcinoma
    Program: VEGA
    Duration: 1. 1. 2009 – 31. 12. 2011
  • Prevalence and medical significance of lymphocytic choriomeningitis virus in Slovak population
    Program: VEGA
    Duration: 1. 1. 2008 – 31. 12. 2010
  • Interplay between lymphocytic choriomeningitis virus and cellular proteins during the persistent infection
    Program: VEGA
    Duration: 1. 1. 2005 – 1. 12. 2007
  • Mutual relationship between hypoxia and oncogenic DNA viruses and its effects on the expression of viral and cellular genes
    Program: VEGA
    Duration: 1. 1. 2005 – 1. 12. 2007
Employees